O-PCE

1. 2026-10-19issueIssued info_card
2. 2026-09-24srcMetabolic profiling of deschloro-N-ethyl-ketamine and identification of new target metabolites in urine and hair using human liver microsomes and high-resolution accurate mass spectrometry
3. 2026-09-24src1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances
4. 2026-09-24srcKetamine-derived designer drug methoxetamine: metabolism including isoenzyme kinetics and toxicological detectability using GC-MS and LC-(HR-)MSn
5. 2026-09-24srcKetamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy
6. 2026-09-24srcCluster of acute poisonings associated with an emerging ketamine analogue, 2-oxo-PCE
7. 2026-09-24srcFatal intoxication related to two new arylcyclohexylamine derivatives (2F-DCK and 3-MeO-PCE)
8. 2026-09-24srcA combined toxicokinetic and metabolic approach to investigate deschloro-N-ethylketamine exposure in a multidrug user
9. 2026-09-24srcThe clinical toxicology of ketamine
10. 2026-09-24srcThe Emergence of Deschloro-N-ethyl-ketamine, a Ketamine Analog, in Drug Seizures and Drug Driving Cases in Hong Kong
11. 2026-09-24srcIn vitro and in vivo metabolic study of three new psychoactive β-keto-arylcyclohexylamines
12. 2026-09-24srcA Fatal Case Involving N-Ethyldeschloroketamine (2-Oxo-PCE) and Venlafaxine
13. 2026-09-24srcPharmacogenetic and drug interaction aspects on ketamine safety in its use as antidepressant - implications for precision dosing
14. 2026-09-24src2-oxo-PCE: ketamine analogue on the streets
15. 2026-09-24srcThe ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor
16. 2026-09-24srcDetermination of Arylcyclohexylamines in Biological Specimens: Sensors and Sample Pre-Treatment Approaches
17. 2026-09-24srcKetamine for Depression, 5: Potential Pharmacokinetic and Pharmacodynamic Drug Interactions
18. 2026-09-24srcTolerance to the cataleptic effect of the N-methyl-D-aspartate (NMDA) receptor antagonists in pigeons: cross-tolerance between PCP-like compounds and competitive NMDA antagonists
19. 2026-09-24srcInteraction of the chiral forms of ketamine with opioid, phencyclidine, sigma and muscarinic receptors
20. 2026-09-24src2-Oxo-PCE (Wikipedia / Grokipedia mirror)
21. 2026-09-24srcDeschloro-N-ethyl Ketamine (O-PCE) Monograph
22. 2026-09-24srcDeschloro-N-ethyl-ketamine Substance Entry
23. 2026-09-04issueIssued emergency
24. 2026-09-04issueIssued info_card
25. 2026-09-04issueIssued notice
26. 2026-06-04proposal43 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
27. 2026-06-04publicationPublication — backfill
28. 2026-04-26revisionRevision 1
29. 2026-04-26absenceSearched PubMed for "2-oxo-PCE O-PCE ketamine analogue acute poisoning emergency" — no results
30. 2026-04-26absenceSearched PubMed for "deschloro-N-ethyl-ketamine O-PCE Hong Kong acute intoxication" — no results
31. 2026-04-26absenceSearched PubMed for "2-oxo-PCE NMDA antagonist dissociative" — no results
32. 2026-04-26absenceSearched ClinicalTrials.gov for "O-PCE eticyclidone dissociative" — no results
33. 2026-04-26genGeneration — pipeline-v5 · with 2 morepipeline-v5
34. 2026-04-26rungeneration run

The same entries, as forms: six forms.